
Baricitinib phosphate

* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS No. | 1187595-84-1 | Cat. No. | BCP15527 |
Name | Baricitinib phosphate | ||
Synonyms | INCB-28050;INCB28050;INCB 28050;LY3009104;LY 3009104;LY-3009104; | ||
SMILES | |||
Chemical Name | |||
Formula | C16H20N7O6PS | M. Wt | 469.41 |
Purity | 98% | Storage | Store at 4-8°C |
Description | INCB028050 inhibits intracellular signaling of multiple proinflammatory cytokines including IL-6 and IL-23 at concentrations <50 nM. Significant efficacy, as assessed by improvements in clinical, histologic and radiographic signs of disease, was achieved in the rat adjuvant arthritis model with doses of INCB028050 providing partial and/or periodic inhibition of JAK1/JAK2 and no inhibition of JAK3 . in vivo: The efficacy following daily oral administration of INCB028050 was assessed at doses of 1, 3, or 10 mg/kg based on its pharmacokinetic profile in this species. Disease severity was assessed periodically, scoring clinical signs of disease. These doses were based on the PK/PD relationship established with the IL-6 WBA, with the goal of inhibiting JAK1/2 signaling by no more than 50% for half of the day. Relative to vehicle-treated animals, increasing doses of INCB028050 inhibited disease scores by 24% (p < 0.05), 57% (p < 0.01), and 81% (p < 0.01), respectively . Baricitinib preferent |
Recommend Products
More >
-
QL-1200186
Cat. No.:BCP49631
No.:2848664-42-4
Product Details -
Filgotinib maleate
Cat. No.:BCP49095
No.:1802998-75-9
Product Details -
Pacritinib citrate
Cat. No.:BCP48998
No.:1228923-42-9
Product Details -
JAK-IN-5 hydrochloride
Cat. No.:BCP48031
No.:2751323-21-2
Product Details -
-
-
-
-
-
Ifidancitinib
Cat. No.:BCP46085
No.:1236667-40-5
Product Details -
Ritlecitinib tosylate
Cat. No.:BCP45991
No.:2192215-81-7
Product Details -
Deuruxolitinib phosphate
Cat. No.:BCP45990
No.:2147706-60-1
Product Details -
-
Tyk2-IN-5
Cat. No.:BCP45577
No.:1797432-62-2
Product Details -
Ilginatinib
Cat. No.:BCP44119
No.:1239358-86-1
Product Details -
Aurora B inhibitor 1
Cat. No.:BCP42843
No.:937276-52-3
Product Details -
-
Upadacitinib hemihydrate
Cat. No.:BCP41039
No.:2050057-56-0
Product Details -
Ruxolitinib racemic
Cat. No.:BCP25428
No.:1160597-27-2
Product Details -
Solcitinib
Cat. No.:BCP23893
No.:1206163-45-2
Product Details

Tags:Baricitinib phosphate supplier,Baricitinib phosphate purchase,Baricitinib phosphate manufacturer,Baricitinib phosphate distributor,Baricitinib phosphate cost,Baricitinib phosphate buy,Baricitinib phosphate for sale